Background: Although pulmonary artery banding (PAB) is a common palliative procedure for pediatric heart malformation, there are concerns of pressure overload and concomitant immune reactions in the right ventricle causing postsurgical complications such as pericardial effusion. At this time, no clear guidelines as to potential risk factors or procedural contraindications have been widely disseminated. Therefore, a study was undertaken to examine wide-ranging factors to find potential biomarkers for postsurgical pericardial effusion formation risk. Methods: A retrospective study was conducted on all cardiac surgeries performed over an eight-year period, and the main inclusion criterion was pericardial effusion development after PAB that required surgical drainage. Nine cases were then analyzed against a control group of 45 cases with respect to body measurements, concomitant surgeries, genetic screens, laboratory tests results, and cardiac function parameters. Results: Trisomy 21 was strongly associated with the development of severe pericardial effusion after PAB, and postoperative serum albumin levels in patients with trisomy 21 were associated with pericardial effusion development. Other parameters showed no significant correlation with pericardial effusion development. Conclusions: Our data indicate a strong association between trisomy 21 and pericardial effusion requiring drainage after PAB, which is in line with translational research findings. Pressure overload from PAB may play a role in the formation of severe pericardial effusion that is exacerbated by cardiac structural defects commonly associated with trisomy 21. Surgical teams should therefore use caution and plan to implement drainage in PAB cases, and postoperative serum albumin may serve as a useful biomarker for pericardial effusion formation.
Introduction
Pulmonary artery banding (PAB) is a common palliative procedure for cardiac malformations with shunt-related pulmonary overflow, especially in low birth weight infants. However, animal modeling has shown that pressure overload as a consequence of PAB accelerates inflammation in the right ventricular myocardium which may lead to pericardial effusion production.
1,2 Such a result may lead to undesirable surgical outcomes if drainage is delayed. [3] [4] [5] As its etiology is poorly understood, postoperative pericardial effusion is often reported as postpericardiotomy syndrome (PPS) and the reported incidence varies widely. 6 As PPS describes any immune-mediated reaction to postsurgical trauma to the pericardium, precise PPS diagnoses are therefore difficult because of overlapping definitions. 7, 8 A preliminary analysis of our institutional experience showed that the most prevalent procedure related to pericardial effusion was PAB. Therefore, in this study, we looked exclusively into PAB cases to elucidate the predictors of postoperative pericardial effusion requiring drainage and tested multiple factors associated with the surgeries, including genomic screening, operation time, and blood testing data.
Materials and Methods
As a preliminary analysis, we reviewed all cardiac surgeries (532 cases) performed at the University of Tsukuba Hospital for structural congenital heart disease between April 2008 and Abbreviations and Acronyms ALB albumin AVSD atrioventricular septal defect DS Down syndrome PAB pulmonary artery banding PPS postpericardiotomy syndrome
July 2016. As a need for drainage can be taken as a measure of pericardial effusion severity, the main inclusion criterion was pericardial effusion after PAB which required drainage. From a safety and reliable outcome perspective, our first choice for pericardial effusion after cardiac surgery is surgical drainage. In these cases, especially when the effusion envelops the heart in the pericardial cavity, we prefer to create a small reopening of the surgical site incision rather than to use other interventional drainage techniques (such as pericardiocentesis). Nineteen cases were selected from the larger patient pool, with 45 nondrainage cases serving as control. Clinical data were reviewed retrospectively. Data collected for comparison included gender, age, height, weight at PAB, and trisomy 21 for patient characteristics. Detailed data for concomitant procedures (arch repair for coarctation or interruption of the aortic arch), approach (lateral thoracotomy or median sternotomy), site of PAB (main or bilateral pulmonary arteries), and if main, length of the banding tape were collected for analysis. Operation time, amount of bleeding, and in/out water balance per body weight during PAB were collected as surgical data. Daily water balance (per body weight), urine amount, and amount of chest tube drainage were also investigated for the first through third postoperative days. Maximum postoperative doses of dopamine and/or epinephrine and peak serum lactate levels were collected to assess cardiac function. Minimum values of serum albumin (ALB) as well as maximum values of blood urea nitrogen, creatinine, white blood cell count, and C-reactive protein were also investigated. Standard descriptive statistics were used to summarize the data and are expressed as median with range. Group comparisons were performed using Mann-Whitney U testing since the data were not normally distributed. Categorical variables are expressed as frequency with percentage. A P value <.05 was taken to indicate statistical significance. Statistical analysis was performed using SPSS statistical software (version 22; IBM SPSS Inc, Armonk, New York). Informed consent was waived because of our retrospective study design, and the study was approved by the Institutional Review Board for Ethics in Human Subject Research of the University of Tsukuba Hospital (Approval No. H29-84).
Results
Postoperative pericardial effusion that required drainage occurred in 19 (3.6%) of 532 cases, and among these, 10 pericardial effusion incidences were after PAB (10 [16.7%] of 60 cases) held during the same period. Five incidents were after closures of isolated ventricular septal defects (5 [5.6%] of 90 cases), with the other four incidents concomitant with four different procedures (repair of atrial septal defect, atrioventricular septal defect (AVSD), systemic-pulmonary shunt for tetralogy of Fallot, and mitral valve replacement). One case with trisomy 18, one case with massive pleural effusion and ascites since the fetal period, and one case that had mediastinitis after PAB were excluded from the study. Three cases that underwent cardiopulmonary bypass for concomitant procedures were also excluded. In total, we experienced 54 cases of PAB, and all procedures were performed as the first palliative surgery without using cardiopulmonary bypass. Among 54 cases, 9 developed eventual moderate-to-severe amount of pericardial effusion after removing the chest tube and required surgical drainage. We compared the perioperative factors between these 9 cases (pericardial effusion group), with 45 other cases that did not develop pericardial effusion (no pericardial effusion group).
The perioperative factors between 9 cases that required surgical drainage for pericardial effusion and 45 cases that did not develop pericardial effusion were compared. All absolute data for each factor are shown in Tables 1 and 2 . The most notable finding was the higher incidence of trisomy 21 within the pericardial effusion group, with 6 of 9 cases in the pericardial effusion group and 10 of 45 in the no pericardial effusion group (P ¼ .008; Table 1 ). Minimum values of ALB after PAB were lower in the pericardial effusion group compared to the no pericardial effusion group (P ¼ .009), while pre-PAB baseline values did not differ between the groups. This difference in minimum ALB after PAB disappeared when we isolated values from the 38 cases without trisomy 21 (Table 2 ). Other perioperative parameters did not differ between groups. Taken together, these data indicate that genetic screening for trisomy 21 may be an important presurgical biomarker for potential development of pericardial effusion after PAB and that postoperative serum ALB may be a useful indicator of pericardial effusion for patients with trisomy 21 who must undergo PAB. Two of the 16 cases with trisomy 21 had hypothyroidism before PAB, and 6 cases developed hypothyroidism soon after PAB. Three of the cases with hypothyroidism were in the pericardial effusion group (three of six cases), and the other five were in the no pericardial effusion group (five of ten cases).
Comment
Pulmonary artery banding has been largely abandoned in leading cardiac centers since the advantages of early primary repair for congenital heart disease became clear. Nevertheless, for immature patients with low birth weight and serious conditions due to complex cardiac malformations, the relatively low invasiveness of PAB makes it a singular choice for palliative control of pulmonary blood flow that also prevents pulmonary vascular obstructive disease. According to the 2014 annual report by the Japanese Association for Thoracic and cardiovascular Surgery, there were 661 PAB performed mostly on newborns and infants, and within the "main procedure" classification, it was the most frequently selected in Japan for congenital heart disease even surpassing the second-place (549 cases) systemic-pulmonary shunt procedure. 9 However, frequent use may not be indicative of superior outcome. Our experience showed a high incidence of postoperative pericardial effusion with PAB. Although no literature has clearly described PAB as a risk factor for postoperative pericardial effusion, hemodynamic and mechanical stress changes accompanying PAB might play a key role in the formation of postoperative pericardial effusion. Recently, the literature reports an activated inflammatory process in the right ventricular myocardium after pressure overload from animal experiments.
1,2 Luitel and colleagues suggested from their murine PAB model that pressure overload leads to right ventricular accumulation and increased activity of cardiac mast Abbreviations: ALB, albumin; AVSD, atrioventricular septal defect; BUN, blood urea nitrogen; CRP, C-reactive protein; CoA, coarctation of the aorta; CRE, creatinine; HLHS, hypoplastic left heart syndrome; IAA, interruption of the aortic arch; LAC, lactate; PAB, pulmonary artery banding; POD, postoperative day; VSD, ventricular septal defect; WBC, white blood cell count.
a Results reported as median (range) or frequency (%).
cells which are known as a component of the inflammatory response in adverse ventricular remodeling. 1 Earlier animal experiments also suggest that multiple molecular mechanisms (such as proteasomal changes and proteins such as Cylindromatosis tumor suppressor protein CYLD) play a synergistic role in this adverse remodeling. 10 Dewachter and colleagues concluded from their canine PAB model that acute afterloadinduced RV failure from PAB is associated with increased myocardial expression of inflammatory cytokines and infiltration of neutrophils and macrophages. 2 Although the exact pathogenesis of postoperative pericardial effusion still remains unclear, underlying inflammation, autoimmune processes, and molecular mechanisms may play a pivotal role in this clinical presentation. 7, 8 Interestingly, the proportion of patients with trisomy 21 was high in the pericardial effusion group. Since there was no difference between groups when we investigated the values exclusively on patients without trisomy 21, postoperative minimum ALB values became a trisomy-associated risk factor instead of an independent one. Therefore, we could conclude that the presence of trisomy 21 is associated with increased likelihood of PAB-induced pericardial effusion that requires surgical drainage. Among various risk factors that have been reported, [11] [12] [13] a recent high-volume cohort study first pointed out trisomy 21 as an independent risk factor predicting postoperative pericardial effusion.
14 In trisomy 21 cases, more popularly known as Down syndrome (DS), pericardial effusion had often been reported with comorbidties such as hypothyroidism, celiac disease, infectious disease, and transient abnormal myelopoiesis. 15, 16 In a critical study, however, Concolino and colleagues showed a significant increase in the prevalence of isolated pericardial effusion in individuals with DS apart from any associated disease or cardiac malformations. 17 From this finding, Elias and colleagues speculated that cardiac surgery and the resulting inflammatory process may provide the trigger to develop a significant postoperative pericardial effusion in children with DS who have a greater propensity to develop pericardial effusion, in general. 14 It is well known that DS, in addition to cardiac malformations with shunt-related pulmonary overflow, contains a higher potential for developing pulmonary vascular obstructive disease. 18 One of the most common shunt-related cardiac malformations associated with DS is the AVSD, so our therapeutic strategy in this case is to achieve precision repair via PAB as an initial palliative in the neonate period to improve immediate condition and prevent the development of pulmonary vascular obstructive disease. We then perform full cardiac repair within the infancy period. Therefore, our experience with high pericardial effusion incidence after PAB might be due to the fact that we are performing PAB on DS-associated AVSD which biases outcomes to pericardial effusion (Figure 1 ).
There are several limitations to this study, including the small number of patients with pericardial effusion and retrospective nature of the study. There is a potential for selection bias in exclusively analyzing severe cases (which may exclude true prevalence), since we limited the study cohort to pericardial effusion cases that required drainage. In less severe cases, pericardial effusion can be self-limiting or spontaneous resolution can occur while first-line treatments such as aspirin, nonsteroidal anti-inflammatory agents, and corticosteroids are commonly used in less severe cases when hemodynamics are not threatened. 12 In conclusion, based on our observations and those of other investigators, patients with DS are prone to develop pericardial effusion after PAB that requires surgical drainage. Postoperative serum ALB may play a role as a biomarker of pericardial effusion formation in patients with DS and should be considered in the recovery plan as an essential laboratory test. 
